Publication: 4722

Publication: 4722

Surgical outcomes in the ALTERNATE trial (Alliance A011106) -a randomized phase 3 Neoadjuvant endocrine therapy (NET) trial in postmenopausal women with clinical stage II/III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC)

Google Scholar

Citation:

Meeting Instance:: SABCS 2025
Year:: 2025
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Genentech, Astra zeneca
Grants:: U10CA180821, U10CA180882; U10CA180868 (NRG Oncology);

Corr. Author:
Authors:: A. Marilyn Leitch Travis Dockter Vera J. Suman Anna Weiss Gary W. Unzeitig Joseph Guenther Souzan Sanati Kiran Vij Jeremy Hoog Ann Abigail Caudle Amy Tiersten Monica Mita Wajeeha Razaq Tina J. Hieken Yang Wang Mothaffar Rimawi Matthew J. Ellis Eric P. Winer Kelly Hunt Ann H. Ann Partridge Lisa A. Carey Cynthia X. Ma.

Networks:: CA016, KY015, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OK003, LAPS-TX011, LAPS-TX035, NEWMEXICO, NY021, NY167, TX041, TX190

Study: Alliance-A011106
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: